Coming Up

Tweet TWEET

iGenomics to Purchase 32 Ion Proton™ Next-Generation Sequencers

       iGenomics to Purchase 32 Ion Proton™ Next-Generation Sequencers

Guangzhou-based startup chooses Ion Torrent for superior speed and flexibility

PR Newswire

CARLSBAD, Calif., Sept. 24, 2013

CARLSBAD, Calif., Sept. 24, 2013 /PRNewswire/ --Life Technologies Corporation
(NASDAQ: LIFE) today announced that iGenomics, a privately held diagnostic
service company based in Guangzhou, China, purchased 17 Ion Proton™ sequencers
and plans to add 15 more instruments by the end of the year. iGenomics, which
also signed a licensing and supply agreement with Life Technologies, will
initially use the sequencers for research in aneuploidy screening, but plans
to expand into other research applications.

iGenomics performed more than 200 sequencing runs on Ion Proton™ sequencers
over the last six months with an optimized protocol that consistently delivers
well over 80 million high-quality, high-accuracy sequencing reads per run on
the Ion PI chips and up to six runs in a single day.

"We've looked closely at all the platforms in the next-generation sequencing
space and only Ion Torrent delivers the speed, accuracy and flexibility we
need to be competitive at a price that makes economic sense for us as a
startup," said iGenomics CEO Shengyu Huang. "We see a huge growth opportunity
in sequencing and believe that Ion Torrent provides the ideal technology to
help us quickly expand and compete in this market today and in the future."

"As the CEO of Daan Gene, I've worked closely with Life Technologies for many
years and have seen firsthand the company's dedication to its partners'
success in the China market," said Xing Yu Zhou, an iGenomics investor. "That
gives me confidence that the Ion Proton platform is the right choice for
iGenomics."

"In just a few months, iGenomics has been able to quickly develop and validate
a novel assay which they are quickly bringing to market,"saidGregory T.
Lucier, Chairman and CEO for Life Technologies. "iGenomics demonstrates again
why Ion Torrent is delivering sequencing for all, from start-ups to big
service providers, around the world."

The Ion Proton™Sequencer is For Research Use Only. Not for use in diagnostic
procedures.

About Life Technologies
Life Technologies Corporation(NASDAQ:LIFE) is a global biotechnology company
that is committed to providing the most innovative products and services to
leading customers in the fields of scientific research, genetic analysis and
applied sciences. With a presence in more than 180 countries, the company's
portfolio of 50,000 end-to-end solutions is secured by more than 5,000 patents
and licenses that span the entire biological spectrum—scientific exploration,
molecular diagnostics, 21^stcentury forensics, regenerative medicine and
agricultural research. Life Technologies has approximately 10,000 employees
and had sales of $3.8 billion in 2012.

Life Technologies' Safe Harbor Statement
This press release includes forward-looking statements about our anticipated
results that involve risks and uncertainties. Some of the information
contained in this press release, including, but not limited to, statements as
to industry trends and Life Technologies' plans, objectives, expectations and
strategy for its business, contains forward-looking statements that are
subject to risks and uncertainties that could cause actual results or events
to differ materially from those expressed or implied by such forward-looking
statements. Any statements that are not statements of historical fact are
forward-looking statements. When used, the words "believe," "plan," "intend,"
"anticipate," "target," "estimate," "expect" and the like, and/or future tense
or conditional constructions ("will," "may," "could," "should," etc.), or
similar expressions, identify certain of these forward-looking statements.
Important factors which could cause actual results to differ materially from
those in the forward-looking statements are detailed in filings made byLife
Technologies with the Securities and Exchange Commission.Life Technologies
undertakes no obligation to update or revise any such forward-looking
statements to reflect subsequent events or circumstances.

(Logo:http://photos.prnewswire.com/prnh/20110216/MM49339LOGO)

Life Technologies Contact:
Wes Conard
415-385-4455
wes.conard@lifetech.com

SOURCE Life Technologies Corporation

Website: http://www.lifetechnologies.com